期刊文献+

睾丸支持细胞免疫豁免功能的机理研究 被引量:5

The study of immune privileged of sertoli cell
暂未订购
导出
摘要 目的 :探讨睾丸支持细胞免疫豁免功能发生的机制。方法 :分离培养 4 8h后的睾丸支持细胞与活化的淋巴细胞共同培养 ,MTT法检测其对淋巴细胞的杀伤作用 ;应用抗FasIgG抗体阻断试验评价睾丸支持细胞杀伤活化的淋巴细胞与Fas/FasL系统之间的关系。结果 :睾丸支持细胞体外可以杀伤活化的淋巴细胞 ,该种杀伤作用可以被抗FasIgG抗体阻断 ,表明睾丸支持细胞通过Fas/FasL系统发挥其免疫豁免功能。结论 :睾丸支持细胞能通过Fas/FasL作用而调节T细胞的活性 ,这可能是睾丸支持细胞提供局部免疫豁免功能的机制之一。 Objective:To investigate the mechanism of immune privileged origin from sertoli cell.Methods:The sertoli cells were cultured together with active lymphocytes to observe the killing effect on lymphocytes by MTT; and the Fas/FasL system was blocked by anti Fas IgG antigen so as to reveal the mechanism of this killing effect.In the meantime,the expression of FasL in sertoli was tested.Resrlts:Sertoli cells can kill active lymphocytes and express the Fas ligand.This killing effect can be blocked by the anti Fas antiboby.It suggested that the killing effect was mediated by Fas/FasL system.Conclusion:Sertoli cells can regulate the activtity of lymphocytes and the FasL expression on sertoli cells may be the mechanism of immune privilege.
出处 《中国现代普通外科进展》 CAS 2004年第1期23-25,共3页 Chinese Journal of Current Advances in General Surgery
基金 四川省科技厅科研基金资助项目 (0 2SY0 2 9 165)
关键词 睾丸支持细胞 T淋巴细胞 FAS/FASL 免疫豁免 Sertoli cells·T l ymphocytes·FAS/FasL·Immune privilege
  • 相关文献

参考文献9

  • 1Suarez-Pinzon W, Korbutt GS, Power R. et al. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-betal-dependent mechanism[J]. Diabetes,2000,49(11) :1810-1818.
  • 2Cameron DF, Hushen JJ, Nazian SJ. Formation of insulin-secreting,Sertolienriched tissue constructs by microgravity coculture of isolated pig islets and rat Sertoli cells[J]. In Vitro Cell Dev Biol Animm ,2001,37(8) :490-498.
  • 3Kimmel SG,Ohbatake M, Kushida M, et al. Murine xenogeneic immuneresponses to the human testis: a presumed immune-privileged tissue[J]. Transplantation, 2000,69 (6): 1075 - 1084.
  • 4Bellgrau D,Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection [J]. Nature, 1995, 377 (6550): 630-632.
  • 5Takeda Y, Gotoh M, Dono K, et al. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts[J]. Diabetologia, 1998,41 (3): 315 - 321.
  • 6Streilein JW. Unraveling immune privilege[J]. Science, 1995,270(5239):1158-1159.
  • 7Yagita H,Seino K,Kayagaki N,et al. CD95 ligand in graft rejection[J]. Nature,1996,379(6567) :682.
  • 8Cameron DF, Hushen J J, Nazian SJ, et al. Formation of Sertoli cell-enriched tissue constructs utilizing simulated microgravity technology[J]. Ann NY Acad Sci, 2001,944: 420-428.
  • 9Willing AE, Cameron DF, Sanberg PR. Sertoli cell transplants:their use in the treatment of neurodegenerative disease[J]. Mol Med Today, 1998,4(11) :471-477.

同被引文献77

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部